Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hooker

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
The AAPS Journal|July 31, 2020
Integrated Item Response Theory Modeling of Multiple Patient-Reported Outcomes Assessing Lower Urinary Tract Symptoms Associated with Benign Prostatic HyperplasiaYassine Kamal Lyauk, Trine Meldgaard Lund, Andrew C Hooker, et al.
The AAPS Journal|February 25, 2021
Bounded Integer Modeling of Symptom Scales Specific to Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaYassine Kamal Lyauk, Daniël M Jonker, Andrew C Hooker, et al.
Psychosomatics|May 15, 2001
A new psychosocial screening instrument for use with cancer patientsJ Zabora, K BrintzenhofeSzoc, P Jacobsen, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depressionA Russu, E Marostica, G De Nicolao, et al.
Plant Disease|May 21, 2019
Occurrence and Distribution of Physiological Races of <i>Exserohilum turcicum</i> in Ontario, CanadaKrishan K Jindal, Albert U Tenuta, Tsegaye Woldemariam, et al.
The AAPS Journal|March 29, 2018
Correction to: Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 21, 2024
Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxiasAlzahra Hamdan, Andrew C Hooker, Xiaomei Chen, et al.
The AAPS Journal|March 9, 2018
Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.
Mycopathologia|June 29, 2005
Modeling effects of environment, insect damage, and Bt genotypes on fumonisin accumulation in maize in Argentina and the PhilippinesRegina de la Campa, David C Hooker, J David Miller, et al.
Journal of Clinical Pharmacology|May 6, 2011
Application of the optimal design approach to improve a pretransplant drug dose finding design for ciclosporinStefanie Hennig, Joakim Nyberg, Samuel Fanta, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
The AAPS Journal|July 31, 2020
Integrated Item Response Theory Modeling of Multiple Patient-Reported Outcomes Assessing Lower Urinary Tract Symptoms Associated with Benign Prostatic HyperplasiaYassine Kamal Lyauk, Trine Meldgaard Lund, Andrew C Hooker, et al.
The AAPS Journal|February 25, 2021
Bounded Integer Modeling of Symptom Scales Specific to Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaYassine Kamal Lyauk, Daniël M Jonker, Andrew C Hooker, et al.
Psychosomatics|May 15, 2001
A new psychosocial screening instrument for use with cancer patientsJ Zabora, K BrintzenhofeSzoc, P Jacobsen, et al.
Clinical Pharmacology and Therapeutics|April 5, 2012
Joint modeling of efficacy, dropout, and tolerability in flexible-dose trials: a case study in depressionA Russu, E Marostica, G De Nicolao, et al.
Plant Disease|May 21, 2019
Occurrence and Distribution of Physiological Races of <i>Exserohilum turcicum</i> in Ontario, CanadaKrishan K Jindal, Albert U Tenuta, Tsegaye Woldemariam, et al.
The AAPS Journal|March 29, 2018
Correction to: Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 21, 2024
Item performance of the scale for the assessment and rating of ataxia in rare and ultra-rare genetic ataxiasAlzahra Hamdan, Andrew C Hooker, Xiaomei Chen, et al.
The AAPS Journal|March 9, 2018
Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in OncologyPhilippe B Pierrillas, Sylvain Fouliard, Marylore Chenel, et al.
Mycopathologia|June 29, 2005
Modeling effects of environment, insect damage, and Bt genotypes on fumonisin accumulation in maize in Argentina and the PhilippinesRegina de la Campa, David C Hooker, J David Miller, et al.
Journal of Clinical Pharmacology|May 6, 2011
Application of the optimal design approach to improve a pretransplant drug dose finding design for ciclosporinStefanie Hennig, Joakim Nyberg, Samuel Fanta, et al.
Pageof 16